Unicorns in Switzerland
Dealroom tracks 40 unicorns headquartered in Switzerland — companies that reached a verified $1B+ valuation — worth $100.5B combined, plus 9 thoroughbreds generating $100M+ in annual revenue. Updated July 2026.
Every unicorn in Switzerland
All 40 companies headquartered in Switzerland that reached a verified $1B+ valuation, ranked by latest valuation. Click a company for its full Dealroom profile.
| # | Company | Sector | HQ | Founded | Valuation | Status |
|---|---|---|---|---|---|---|
| 1 | Actelion Pharmaceuticals | Biotech & Life Sciences | Baden | 1997 | $30B | IPO 2013 |
| 2 | On | eCommerce & Marketplaces | Zurich | 2010 | $11B | IPO 2021 |
| 3 | Temenos | Fintech | Geneva | 1993 | $5B | IPO 2003 |
| 4 | Sonar | Other B2B Software | Vernier | 2008 | $4.7B | Private |
| 5 | Ypsomed | Health Tech & Medtech | Bern | 2003 | $3.6B | IPO 2004 |
| 6 | Acronis | Cybersecurity | Schaffhausen | 2002 | $3.5B | Private |
| 7 | Sportradar | Other | St. Gallen | 2001 | $3.4B | IPO 2021 |
| 8 | INFICON | Semiconductors | Bad Ragaz | 1996 | $3.2B | IPO 2000 |
| 9 | CRISPR Therapeutics | Biotech & Life Sciences | Basel | 2013 | $3.1B | IPO 2016 |
| 10 | Nexthink | Other B2B Software | Prilly | 2004 | $3B | Private |
| 11 | Climeworks | Energy | Zurich | 2009 | $2.8B | Private |
| 12 | AutoForm | Transportation | Freienbach | 1995 | $2B | Private |
| 13 | 21.co | Fintech | Zurich | 2018 | $2B | Private |
| 14 | Idorsia | Biotech & Life Sciences | Allschwil | 2017 | $2B | IPO 2017 |
| 15 | Swixx Biopharma | Biotech & Life Sciences | Baar | 2014 | $1.6B | Private |
| 16 | MindMaze | Biotech & Life Sciences | Lausanne | 2012 | $1.5B | Private |
| 17 | NBE-Therapeutics | Biotech & Life Sciences | Basel | 2012 | $1.3B | Private |
| 18 | Implantica | Health Tech & Medtech | Switzerland | 2003 | $1.3B | IPO 2020 |
| 19 | Oculis | Biotech & Life Sciences | Saint-Sulpice | 2017 | $1.3B | Private |
| 20 | BETA CAE Systems | Aviation | Root | 1990 | $1.2B | Private |
| 21 | NovoCure | Biotech & Life Sciences | Root | 2000 | $1.2B | IPO 2015 |
| 22 | Araris Biotech | Biotech & Life Sciences | Wädenswil | 2019 | $1.1B | Private |
| 23 | Beekeeper | Cybersecurity | Zurich | 2012 | $1.1B | Private |
| 24 | Orderfox | AI | Zurich | 2017 | $1.1B | Private |
| 25 | Ascensia Diabetes Care | Health Tech & Medtech | Basel | 2016 | $1.1B | Private |
| 26 | VectivBio | Biotech & Life Sciences | Basel | 2019 | $1B | IPO 2021 |
| 27 | vVardis | Health Tech & Medtech | Baar | 2019 | $1B | Private |
| 28 | South Pole | Fintech | Zurich | 2006 | $1B | Private |
| 29 | Sygnum | Fintech | Zurich | 2018 | $1B | Private |
| 30 | Scandit | AI | Zurich | 2009 | $1B | Private |
| 31 | Medartis | Health Tech & Medtech | Basel | 1997 | $944M | IPO 2018 |
| 32 | Sensirion | Semiconductors | Zurich | 1998 | $899M | IPO 2018 |
| 33 | u-blox | Semiconductors | Zurich | 1997 | $889M | IPO 2007 |
| 34 | Energy Vault | Energy | Lugano | 2017 | $815M | IPO 2022 |
| 35 | Kuros Biosciences | Biotech & Life Sciences | Zurich | 2000 | $739M | IPO 2016 |
| 36 | Zur Rose Group | Biotech & Life Sciences | Frauenfeld | 1993 | $498M | IPO 2017 |
| 37 | Sophia Genetics | Biotech & Life Sciences | Saint-Sulpice | 2011 | $372M | IPO 2021 |
| 38 | ADC Therapeutics | Biotech & Life Sciences | Epalinges | 2011 | $336M | IPO 2020 |
| 39 | Lastminute.com | eCommerce & Marketplaces | Chiasso | 1998 | $57M | IPO 2000 |
| 40 | Leonteq | Fintech | Zurich | 2007 | $-3227M | IPO 2012 |
Thoroughbreds — the $100M+ revenue tier
Dealroom's revenue milestone: 9 Switzerland companies past $100M in annual revenue, proof of traction beyond paper valuations.
| # | Company | Sector | HQ | Founded | Valuation | Status |
|---|---|---|---|---|---|---|
| 1 | Oviva | Health Tech & Medtech | Zurich | 2013 | $1.4B | Private |
| 2 | Basilea Pharmaceutica | Biotech & Life Sciences | Allschwil | 2000 | $535M | IPO 2004 |
| 3 | Crescendo | AI | Geneva | 2023 | $500M | Private |
| 4 | Trifork | AI | Feusisberg | 1996 | $346M | IPO 2021 |
| 5 | AC Immune | Biotech & Life Sciences | Lausanne | 2003 | $188M | IPO 2016 |
| 6 | SwissBorg | Fintech | Lausanne | 2017 | $138M | Private |
| 7 | Molecular Partners | Biotech & Life Sciences | Zurich | 2004 | $46M | IPO 2014 |
| 8 | Bexio | Fintech | Rapperswil-Jona | 2013 | $41M | Private |
| 9 | Bravofly | Aviation | Chiasso | 2006 | — | IPO 2014 |
Frequently asked questions
How many unicorns are there in Switzerland?
Dealroom tracks 40 unicorns headquartered in Switzerland as of July 2026, worth $100.5B combined. 1 of them are valued at $10B or more.
What are the biggest unicorns in Switzerland?
The three most valuable are Actelion Pharmaceuticals, On, Temenos. Zurich is the top hub with 12 of them.
What counts as a unicorn — and what is a thoroughbred?
A unicorn is a company that reached a $1B+ valuation, verified by Dealroom. A thoroughbred is Dealroom's revenue-based tier: a startup-era company generating $100M+ in annual revenue — traction, not just paper valuation.